Clinical Trial Update: Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine in metastatic breast cancer previously treated with doxorubicin and paclitaxel has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED